Liu W - Search Results

1

Changes of N6-methyladenosine modulators promote breast cancer progression.

Wu L, Wu D, Ning J, Liu W, Zhang D. Wu L, et al. Among authors: liu w. BMC Cancer. 2019 Apr 5;19(1):326. doi: 10.1186/s12885-019-5538-z. BMC Cancer. 2019. PMID: 30953473 Free PMC article.

2

Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer.

Liu W, Ning J, Li C, Hu J, Meng Q, Lu H, Cai L. Liu W, et al. Tumour Biol. 2016 May;37(5):6331-6. doi: 10.1007/s13277-015-4480-1. Epub 2015 Dec 1. Tumour Biol. 2016. PMID: 26628299

3

Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.

Chen J, Zhuang Y, Wang P, Ning J, Liu W, Huang Y, Lin X, Peng L, Zhang D. Chen J, et al. Among authors: liu w. Cell Death Dis. 2022 Mar 7;13(3):216. doi: 10.1038/s41419-022-04661-8. Cell Death Dis. 2022. PMID: 35256595 Free PMC article.

4

Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC.

Ning J, Wang F, Zhu K, Li B, Shu Q, Liu W. Ning J, et al. Among authors: liu w. Front Genet. 2021 Dec 1;12:779155. doi: 10.3389/fgene.2021.779155. eCollection 2021. Front Genet. 2021. PMID: 34925461 Free PMC article.

5

Navigating into the binding pockets of the HER family protein kinases: discovery of novel EGFR inhibitor as antitumor agent.

Liu W, Ning JF, Meng QW, Hu J, Zhao YB, Liu C, Cai L. Liu W, et al. Among authors: liu c. Drug Des Devel Ther. 2015 Jul 23;9:3837-51. doi: 10.2147/DDDT.S85357. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26229444 Free PMC article.

6

Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma.

Liu W, Dong Z, Liang J, Guo X, Guo Y, Shen S, Kuang G, Guo W. Liu W, et al. Cancer Invest. 2016 Nov 25;34(10):506-516. doi: 10.1080/07357907.2016.1242010. Epub 2016 Oct 28. Cancer Invest. 2016. PMID: 27791400

7

USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.

Hu J, Yang D, Zhang H, Liu W, Zhao Y, Lu H, Meng Q, Pang H, Chen X, Liu Y, Cai L. Hu J, et al. Among authors: liu y, liu w. Lung Cancer. 2015 Jun;88(3):239-45. doi: 10.1016/j.lungcan.2015.02.019. Epub 2015 Mar 10. Lung Cancer. 2015. PMID: 25907317

8

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.

Gong J, Liu T, Fan Q, Bai L, Bi F, Qin S, Wang J, Xu N, Cheng Y, Bai Y, Liu W, Wang L, Shen L. Gong J, et al. Among authors: liu w, liu t. BMC Cancer. 2016 Feb 8;16:68. doi: 10.1186/s12885-016-2092-9. BMC Cancer. 2016. PMID: 26857702 Free PMC article. Clinical Trial.

9

The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.

Zhou X, Wang Y, Shan B, Han J, Zhu H, Lv Y, Fan X, Sang M, Liu XD, Liu W. Zhou X, et al. Among authors: liu xd, liu w. Med Oncol. 2015 Jan;32(1):428. doi: 10.1007/s12032-014-0428-3. Epub 2014 Dec 12. Med Oncol. 2015. PMID: 25502084

10

Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion.

Ma L, Lan F, Zheng Z, Xie F, Wang L, Liu W, Han J, Zheng F, Xie Y, Huang Q. Ma L, et al. Among authors: liu w. Mol Cancer. 2012 Oct 21;11:79. doi: 10.1186/1476-4598-11-79. Mol Cancer. 2012. PMID: 23083134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58,637 results

Search Page

Filters